Breast implants are back in the news again. This time breast cancer patients are not getting the attention from the FDA they deserve.
Report Discusses Role Of FDA In Determining Safety Of Reconstructive Breast Implants
“Decisions in the Dark: The FDA, Breast Cancer Survivors and Silicone Implants,” National Research Center for Women and Families: The report looks at the lack of short- and long-term data manufacturers provide to FDA on the safety of silicone breast implants for breast cancer patients.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.